Coldstream Capital Management’s Integra LifeSciences IART Stock Holding History

Coldstream Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$97.3K	Buy	+10,332	New	+$113K	﹤0.01%	1161
2025 Q2	–	Sell	-5,474	Closed	-$120K	–	2122
2025 Q1	$120K	Buy	+5,474	New	+$129K	﹤0.01%	1256
2019 Q4	–	Sell	-3,329	Closed	-$200K	–	359
2019 Q3	$200K	Buy	+3,329	New	+$198K	0.02%	322
2018 Q4	–	Sell	-3,957	Closed	-$261K	–	348
2018 Q3	$261K	Buy	3,957 +112	+3%	+$6.96K	0.02%	286
2018 Q2	$248K	Buy	3,845 +105	+3%	+$6.5K	0.03%	274
2018 Q1	$207K	Buy	+3,740	New	+$196K	0.02%	277
2017 Q3	–	Sell	-3,745	Closed	-$204K	–	310
2017 Q2	$204K	Buy	+3,745	New	+$179K	0.03%	264

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Coldstream Capital Management's IART Position: Q1 2026 in Review

Coldstream Capital Management opened a new position in Integra LifeSciences (IART) in Q1 2026: 10,332 shares worth $97.3K. The stake represents ﹤0.01% of the portfolio and ranks #1161 among its holdings. This is a return to the name: Coldstream Capital Management previously reported a position in IART as recently as Q1 2025.

Coldstream Capital Management first reported a position in IART in Q2 2017 and has held it in 7 quarters since. The position peaked at $261K in Q3 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Coldstream Capital Management held 10,332 shares of Integra LifeSciences worth $97.3K as of Q1 2026.
Integra LifeSciences was a new Coldstream Capital Management position in Q1 2026.
Integra LifeSciences made up ﹤0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #1161 holding.
Coldstream Capital Management first reported a position in Integra LifeSciences in Q2 2017 and has held it in 7 quarters since.
Coldstream Capital Management's Integra LifeSciences position peaked at $261K in Q3 2018.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.